taurine has been researched along with Colonic Neoplasms in 43 studies
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The human colon carcinoma cell line HT-29, when grown to confluence, was found to take up taurine and accumulate it against a concentration gradient from a NaCl-containing uptake medium." | 7.68 | Constitutive expression of the taurine transporter in a human colon carcinoma cell line. ( Brandsch, M; Ganapathy, V; Leibach, FH; Miyamoto, Y; Tiruppathi, C, 1992) |
| "Among these patients, 8 developed hyperbilirubinemia." | 5.33 | [Efficacy of the combined use of taurine for hyperbilirubinemia caused by UFT therapy after surgery for colonic cancer]. ( Fujii, K; Iizuka, R; Ikawa, O; Izumi, H; Kakihara, N; Katoh, Y; Matsumura, H; Miyata, K; Ohgaki, M; Shimomura, K; Shimotsuma, M; Tkenaka, A, 2006) |
| " The aim of this prospective study was to observe the influence of long-term intravenous taurolidine on the development of lung metastases after intravenous injection of colon adenocarcinoma cells." | 3.75 | Taurolidine in the prevention and therapy of lung metastases. ( Beshay, M; Bilici, M; Gazdhar, A; Gugger, M; Hoksch, B; Rufer, B; Schmid, RA, 2009) |
| "0% taurolidine on the invasion of 1 x 10(5) CC531 adenocarcinoma cells." | 3.73 | Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats. ( Krüger, S; Lippert, H; Nestler, G; Pross, M; Schubert, D; Schulz, HU, 2005) |
| "VEGF and TNFalpha levels of rat colon adenocarcinoma cells (DHD/K12/TRb) were analyzed in the supernatant undergoing treatment of increasing taurolidine doses in vitro." | 3.73 | Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats. ( Braumann, C; Jacobi, CA; Kilian, M; Menenakos, C; Schoenbeck, M, 2005) |
| "The effect of taurolidine, heparin, and povidone-iodine on the growth of colon adenocarcinoma DHD/K12/TRb was measured in rats undergoing laparoscopy with carbon dioxide (n = 40), helium (n = 40), or xenon (n = 40)." | 3.70 | Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model. ( Jacobi, CA; Müller, JM; Volk, T; Wildbrett, P, 1999) |
| "The effects of taurolidine, heparin, and povidone iodine on the growth of rat and human colon adenocarcinoma as well as gallbladder carcinoma were investigated in vitro." | 3.70 | New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat. ( Jacobi, CA; Müller, JM; Ordemann, J; Peter, FJ; Wenger, FA, 1999) |
| "The effect of taurolidine and heparin on growth of colon adenocarcinoma DHD/K12/TRb was measured in vitro and in vivo." | 3.69 | Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. ( Böhm, B; Jacobi, CA; Müller, JM; Ordemann, J; Sabat, R; Zieren, HU, 1997) |
| "In order to prevent tumor metastases, the effect of taurolidine and heparin on the growth of colon adenocarcinoma DHD/K12/TRb was measured in vitro and in a rat model." | 3.69 | [Peritoneal instillation of taurolidine and heparin for preventing intraperitoneal tumor growth and trocar metastases in laparoscopic operations in the rat model]. ( Jacobi, CA; Müller, JM; Ordemann, J; Sabat, R; Volk, HD; Wenger, F, 1997) |
| "The human colon carcinoma cell line HT-29, when grown to confluence, was found to take up taurine and accumulate it against a concentration gradient from a NaCl-containing uptake medium." | 3.68 | Constitutive expression of the taurine transporter in a human colon carcinoma cell line. ( Brandsch, M; Ganapathy, V; Leibach, FH; Miyamoto, Y; Tiruppathi, C, 1992) |
| "We have studied the influence of the peripheral vasodilator hydralazine (HDZ) on the vasculature and blood perfusion of two members of a series of subcutaneous murine adenocarcinomata of the colon (MAC tumours), and the influence of HDZ on the efficacy and/or toxicity of TCNU and melphalan." | 3.68 | The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours. ( Bibby, MC; Cox, JA; Crawford, SM; Quinn, PK, 1992) |
| "Peri-operative inflammation has been extensively highlighted in cancer patients as detrimental." | 2.87 | RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial. ( Foley, N; Jinih, M; Neary, PM; O'Connell, E; O'Leary, DP; Pfirrmann, RW; Redmond, HP; Wang, JH, 2018) |
| " Morphological changes with respect to increasing taurolidine dosage were visualized and monitored using electron microscopy." | 1.72 | Exploring the potential of taurolidine in inducing mobilization and detachment of colon cancer cells: a preliminary in-vitro study. ( Khosrawipour, T; Khosrawipour, V; Kielan, W; Labbé, MK; Lau, H; Li, S; Migdal, P; Mikolajczyk, A; Nicpon, J; Stieglitz, S, 2022) |
| " An increasing dosage of TN (from 0." | 1.51 | Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC). ( Arafkas, M; Chaudhry, H; Khosrawipour, T; Khosrawipour, V; Knoefel, WT; Pigazzi, A; Schubert, J, 2019) |
| "BACKGROUND Colon cancer is one of the most prevalent and deadly cancers worldwide." | 1.43 | Overexpression of Long Non-Coding RNA TUG1 Promotes Colon Cancer Progression. ( Hu, JC; Jiang, LX; Qu, Z; Sui, MH; Sun, HQ; Yu, X; Zhai, HY; Zheng, HT; Zhou, K, 2016) |
| "Taurine (Tau) has been shown to possess cancer therapeutic effect through induction of apoptosis, while the underlying molecular mechanism of its anti-cancer effect is not well understood." | 1.40 | Mechanism of taurine-induced apoptosis in human colon cancer cells. ( Tu, S; Wan, F; Wang, Y; Xu, B; Zhang, X, 2014) |
| "Surgical cytoreduction of peritoneal surface malignancy of colorectal origin in combination with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) has become an established treatment approach." | 1.36 | Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model. ( Atanassow, V; Braumann, C; Caldenas, S; Hartmann, J; Kilian, M; Makareinis, A; Raue, W; Schwenk, W, 2010) |
| "330 mg) of intraperitoneal metastases in comparison to the control group (p = 0." | 1.34 | Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model. ( Braumann, C; Jacobi, CA; Mueller, JM; Opitz, I; Van der Veen, H; Witte, N, 2007) |
| "Among these patients, 8 developed hyperbilirubinemia." | 1.33 | [Efficacy of the combined use of taurine for hyperbilirubinemia caused by UFT therapy after surgery for colonic cancer]. ( Fujii, K; Iizuka, R; Ikawa, O; Izumi, H; Kakihara, N; Katoh, Y; Matsumura, H; Miyata, K; Ohgaki, M; Shimomura, K; Shimotsuma, M; Tkenaka, A, 2006) |
| "Taurolidine has been successfully used as a disinfectant and to prevent the spreading and growth of tumor cells after surgical excision." | 1.32 | The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis. ( Braumann, C; Dubiel, W; Henke, W; Jacobi, CA, 2004) |
| " The results show that the route of administration influences plasma concentrations, bioavailability and tissue and tumour concentrations." | 1.27 | Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations. ( Bibby, MC; Bloomer, JC; Double, JA; Loadman, PM, 1988) |
| " Dose-response curves generated at increasing exposure times suggest that no active or long lived products of TCNU are formed as a result of the drug's spontaneous breakdown in vitro (rate of breakdown was 0." | 1.27 | In vitro and in vivo responses of a panel of murine colon tumours to TCNU: a positive correlation. ( Bibby, MC; Double, JA; Phillips, RM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (11.63) | 18.7374 |
| 1990's | 14 (32.56) | 18.2507 |
| 2000's | 16 (37.21) | 29.6817 |
| 2010's | 5 (11.63) | 24.3611 |
| 2020's | 3 (6.98) | 2.80 |
| Authors | Studies |
|---|---|
| Mikolajczyk, A | 1 |
| Khosrawipour, V | 2 |
| Lau, H | 1 |
| Li, S | 1 |
| Migdal, P | 1 |
| Labbé, MK | 1 |
| Kielan, W | 1 |
| Nicpon, J | 1 |
| Stieglitz, S | 1 |
| Khosrawipour, T | 2 |
| Chatelaine, HA | 1 |
| Ramazani, CA | 1 |
| Spencer, K | 1 |
| Olivo-Marston, S | 1 |
| Bailey, MT | 1 |
| McElroy, J | 1 |
| Hatzakis, E | 1 |
| Mathé, EA | 1 |
| Kopec, RE | 1 |
| Jiménez-Alonso, JJ | 1 |
| Guillén-Mancina, E | 1 |
| Calderón-Montaño, JM | 1 |
| Jiménez-González, V | 1 |
| Díaz-Ortega, P | 1 |
| Burgos-Morón, E | 1 |
| López-Lázaro, M | 1 |
| Redmond, HP | 1 |
| Neary, PM | 1 |
| Jinih, M | 1 |
| O'Connell, E | 1 |
| Foley, N | 1 |
| Pfirrmann, RW | 2 |
| Wang, JH | 1 |
| O'Leary, DP | 1 |
| Schubert, J | 1 |
| Chaudhry, H | 1 |
| Arafkas, M | 1 |
| Knoefel, WT | 1 |
| Pigazzi, A | 1 |
| Zhang, X | 1 |
| Tu, S | 1 |
| Wang, Y | 1 |
| Xu, B | 1 |
| Wan, F | 1 |
| Zhai, HY | 1 |
| Sui, MH | 1 |
| Yu, X | 1 |
| Qu, Z | 1 |
| Hu, JC | 1 |
| Sun, HQ | 1 |
| Zheng, HT | 1 |
| Zhou, K | 1 |
| Jiang, LX | 1 |
| Hoksch, B | 1 |
| Rufer, B | 1 |
| Gazdhar, A | 1 |
| Bilici, M | 1 |
| Beshay, M | 1 |
| Gugger, M | 1 |
| Schmid, RA | 1 |
| Raue, W | 1 |
| Kilian, M | 3 |
| Braumann, C | 9 |
| Atanassow, V | 1 |
| Makareinis, A | 1 |
| Caldenas, S | 1 |
| Schwenk, W | 1 |
| Hartmann, J | 1 |
| Opitz, I | 3 |
| van der Veen, HC | 1 |
| Ablassmaier, B | 1 |
| Führer, K | 1 |
| Jacobi, CA | 12 |
| Wersinger, C | 2 |
| Rebel, G | 2 |
| Lelong-Rebel, I | 1 |
| Ordemann, J | 4 |
| Wenger, FA | 2 |
| Henke, W | 1 |
| Dubiel, W | 1 |
| Mochizuki, T | 1 |
| Satsu, H | 1 |
| Nakano, T | 1 |
| Shimizu, M | 1 |
| Nestler, G | 1 |
| Schulz, HU | 1 |
| Schubert, D | 1 |
| Krüger, S | 1 |
| Lippert, H | 1 |
| Pross, M | 1 |
| Stuhldreier, B | 1 |
| Bobrich, E | 2 |
| Menenakos, C | 4 |
| Rogalla, S | 1 |
| Schoenbeck, M | 1 |
| Cantin, AM | 1 |
| Bilodeau, G | 1 |
| Ouellet, C | 1 |
| Liao, J | 1 |
| Hanrahan, JW | 1 |
| Ridlon, JM | 1 |
| Kang, DJ | 1 |
| Hylemon, PB | 1 |
| Miyata, K | 1 |
| Ikawa, O | 1 |
| Izumi, H | 1 |
| Shimomura, K | 1 |
| Matsumura, H | 1 |
| Kakihara, N | 1 |
| Katoh, Y | 1 |
| Ohgaki, M | 1 |
| Iizuka, R | 1 |
| Fujii, K | 1 |
| Shimotsuma, M | 1 |
| Tkenaka, A | 1 |
| Kristiansen, G | 1 |
| Van der Veen, H | 1 |
| Witte, N | 1 |
| Mueller, JM | 1 |
| Atanassov, V | 1 |
| Guenther, N | 1 |
| Láng, I | 1 |
| Feuer, L | 1 |
| Nèkám, K | 1 |
| Török, K | 1 |
| Kalmár, L | 1 |
| Gergely, P | 1 |
| Teder, H | 1 |
| Johansson, CJ | 1 |
| d'Argy, R | 1 |
| Lundin, N | 1 |
| Gunnarsson, PO | 1 |
| Taal, BG | 1 |
| Ten Bokkel Huinink, WW | 1 |
| Rodenhuis, S | 1 |
| Reddy, BS | 1 |
| Rao, CV | 1 |
| Rivenson, A | 1 |
| Kelloff, G | 1 |
| Singh, G | 1 |
| Graffner, HO | 1 |
| Milsom, JW | 1 |
| Chaudry, IH | 1 |
| Brandsch, M | 2 |
| Miyamoto, Y | 2 |
| Ganapathy, V | 2 |
| Leibach, FH | 2 |
| Moreno, A | 1 |
| Arús, C | 1 |
| Grossie, VB | 1 |
| Wingenfeld, P | 1 |
| Michalk, DV | 1 |
| Sonntag, A | 1 |
| Paas, S | 1 |
| Minor, T | 1 |
| Isselhard, W | 1 |
| Böhm, B | 1 |
| Zieren, HU | 1 |
| Sabat, R | 2 |
| Müller, JM | 4 |
| Wenger, F | 1 |
| Volk, HD | 1 |
| Wildbrett, P | 1 |
| Volk, T | 1 |
| Peter, FJ | 1 |
| Lelong-Rebel, IH | 1 |
| Tiruppathi, C | 1 |
| Quinn, PK | 1 |
| Bibby, MC | 4 |
| Cox, JA | 1 |
| Crawford, SM | 1 |
| Atassi, G | 1 |
| Dumont, P | 1 |
| Gosse, C | 1 |
| Fournier, JP | 1 |
| Gouyette, A | 1 |
| Roger, P | 1 |
| Double, JA | 3 |
| Loadman, PM | 1 |
| Bloomer, JC | 1 |
| Morris, CM | 1 |
| Phillips, RM | 1 |
1 review available for taurine and Colonic Neoplasms
| Article | Year |
|---|---|
Bile salt biotransformations by human intestinal bacteria.
Topics: Amidohydrolases; Amino Acid Sequence; Bacteria; Bile Acids and Salts; Biotransformation; Cholic Acid | 2006 |
1 trial available for taurine and Colonic Neoplasms
| Article | Year |
|---|---|
RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Biomarkers; Chemotherapy, Adjuvant; Colectomy | 2018 |
41 other studies available for taurine and Colonic Neoplasms
| Article | Year |
|---|---|
Exploring the potential of taurolidine in inducing mobilization and detachment of colon cancer cells: a preliminary in-vitro study.
Topics: Antineoplastic Agents; Colonic Neoplasms; Humans; Oxaliplatin; Taurine; Thiadiazines; Tumor Microenv | 2022 |
Dietary Energy Intake and Presence of Aberrant Crypt Foci Are Associated with Phospholipid, Purine, and Taurine Metabolite Abundances in C57BL/6N Mouse Colon.
Topics: Aberrant Crypt Foci; Animals; Azoxymethane; Carcinogens; Colon; Colonic Neoplasms; Diet; Energy Inta | 2022 |
Artificial Diets with Altered Levels of Sulfur Amino Acids Induce Anticancer Activity in Mice with Metastatic Colon Cancer, Ovarian Cancer and Renal Cell Carcinoma.
Topics: Amino Acids, Sulfur; Animals; Carcinoma, Renal Cell; Caseins; Colonic Neoplasms; Cysteine; Diet; Fem | 2023 |
Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC).
Topics: Aerosols; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Colonic Neo | 2019 |
Mechanism of taurine-induced apoptosis in human colon cancer cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Base Sequence; Cell Proliferation; Colonic Neoplasms; DNA | 2014 |
Overexpression of Long Non-Coding RNA TUG1 Promotes Colon Cancer Progression.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colo | 2016 |
Taurolidine in the prevention and therapy of lung metastases.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Lung Neoplasms; | 2009 |
Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Chemotherapy, Adjuvant; Colonic Neoplasm | 2010 |
The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cellulose, Oxidized; Colonic Neoplasms; Disease Mode | 2003 |
Effect of taurine and other antioxidants on the growth of colon carcinoma cells in the presence of doxorubicin or vinblastine in hypoxic or in ambient oxygen conditions: effect of antioxidants on the action of antineoplastic drugs in MDR and non-MDR cells
Topics: Antineoplastic Agents; Antioxidants; Cell Division; Colonic Neoplasms; Doxorubicin; Drug Resistance, | 2003 |
Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Di | 2003 |
The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis.
Topics: Adenocarcinoma; Antineoplastic Agents; Bacteria; Colonic Neoplasms; Dose-Response Relationship, Drug | 2004 |
Regulation of the human taurine transporter by TNF-alpha and an anti-inflammatory function of taurine in human intestinal Caco-2 cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Cell Line; Cell Line, Tumor; Colonic | 2004 |
Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Colonic Neoplasms; | 2005 |
High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biopsy; Cell Division; Cell Line, Tumor; Chemical an | 2005 |
Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Colonic Neoplasms; In | 2005 |
Oxidant stress suppresses CFTR expression.
Topics: Adenocarcinoma; Antioxidants; Cell Line, Tumor; Colonic Neoplasms; Cyclic AMP; Cystic Fibrosis Trans | 2006 |
[Efficacy of the combined use of taurine for hyperbilirubinemia caused by UFT therapy after surgery for colonic cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Dr | 2006 |
Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
Topics: Adenocarcinoma; Animals; Anticoagulants; Antineoplastic Agents; Cadherins; Cell Adhesion Molecules; | 2007 |
Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model.
Topics: Abdominal Neoplasms; Adenocarcinoma; Animals; Anticoagulants; Antineoplastic Agents; Colonic Neoplas | 2007 |
Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Leukopoiesis; M | 2008 |
Effect of treatment with glutaurine on human antibody-dependent cell-mediated cytotoxicity (ADCC).
Topics: Adult; Aged; Animals; Antibody-Dependent Cell Cytotoxicity; Breast Neoplasms; Colonic Neoplasms; Fem | 1981 |
The effect of different dose levels of degradable starch microspheres (Spherex) on the distribution of a cytotoxic drug after regional administration to tumour-bearing rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carbon Radioisotopes; Colonic Neoplasms; Injections, | 1995 |
Tauromustine (TCNU) combined with 5-fluorouracil and leucovorin in the treatment of advanced colon cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil | 1993 |
Chemoprevention of colon carcinogenesis by organosulfur compounds.
Topics: Acetylcysteine; Allyl Compounds; Anethole Trithione; Animals; Anticarcinogenic Agents; Azoxymethane; | 1993 |
Tauromustine is more effective than conventional chemotherapy in the treatment of colonic tumors.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 1993 |
Regulation of taurine transport in human colon carcinoma cell lines (HT-29 and Caco-2) by protein kinase C.
Topics: Biological Transport; Colchicine; Colonic Neoplasms; Cycloheximide; Cytochalasin D; Dactinomycin; Hu | 1993 |
Quantitative and qualitative characterization of 1H NMR spectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumours can be detected in intact biopsies.
Topics: Biopsy; Colonic Neoplasms; Female; Glutathione; Humans; Inositol; Intestinal Mucosa; Magnetic Resona | 1996 |
Citrulline and arginine increase the growth of the Ward colon tumor in parenterally fed rats.
Topics: Animals; Arginine; Citrulline; Colonic Neoplasms; Glutamine; Male; Ornithine; Parenteral Nutrition; | 1996 |
Protective effect of taurine on hypoxia and reoxygenation-induced damage of human colon cells (HT 29).
Topics: Adenosine; Aerobiosis; Allopurinol; Cell Hypoxia; Cell Line; Cell Survival; Colon; Colonic Neoplasms | 1996 |
Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model.
Topics: Adenocarcinoma; Animals; Cell Division; Colonic Neoplasms; Disease Models, Animal; Drug Combinations | 1997 |
[Peritoneal instillation of taurolidine and heparin for preventing intraperitoneal tumor growth and trocar metastases in laparoscopic operations in the rat model].
Topics: Adenocarcinoma; Animals; Anti-Infective Agents, Local; Cell Division; Colonic Neoplasms; Dose-Respon | 1997 |
Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model.
Topics: Adenocarcinoma; Animals; Anti-Infective Agents; Anticoagulants; Carbon Dioxide; Colonic Neoplasms; H | 1999 |
New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: results of a tumor model in the rat.
Topics: Adenocarcinoma; Animals; Anti-Infective Agents, Local; Carbon Dioxide; Colonic Neoplasms; Gallbladde | 1999 |
Detailed study of the different taurine uptake systems of colon LoVo MDR and non-MDR cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Colon; Col | 2000 |
Constitutive expression of the taurine transporter in a human colon carcinoma cell line.
Topics: Alanine; Biological Transport; Carcinoma; Carrier Proteins; Chlorides; Colonic Neoplasms; Culture Me | 1992 |
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.
Topics: Adenocarcinoma; Animals; Bone Marrow; Cell Division; Cell Line; Colonic Neoplasms; Hydralazine; Male | 1992 |
Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Dose-Response Relatio | 1989 |
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Colon | 1988 |
Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Dose-Respon | 1988 |
In vitro and in vivo responses of a panel of murine colon tumours to TCNU: a positive correlation.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Colonic Neoplasms; Colony-Forming Units As | 1988 |